AKT1 and cancer: According to recent studies, the activation of AKT/mTOR signaling pathway leads to radiotherapy resistance in various cancers, and many valuable inhibitors have been developed targeting AKT/mTOR, such as MK-2206, AZD5363, BI860585, GDC-0349, etc. [12].